Kawasaki disease preceding haemophagocytic lymphohistiocytosis: Challenges for developing world practitioners

Pediatric Blood and Cancer

Volumn 54, Issue 7, 2010, Pages 1023-1025

  Hendricks, Marc ^a   Pillay, Shakti ^b   Davidson, Alan ^a   De Decker, Rik ^a   Lawrenson, John ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Haemophagocytic lymphohistiocytosis; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; C REACTIVE PROTEIN; CD68 ANTIGEN; CEFTRIAXONE; COTRIMOXAZOLE; DEXAMETHASONE; FERRITIN; FIBRINOGEN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; OMEPRAZOLE; TRIACYLGLYCEROL;

ANEMIA; ANOREXIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILD; CLINICAL FEATURE; CORONARY ARTERY ANOMALY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; ERYTHEMA; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; FOOT EDEMA; FOOT SOLE; HAND EDEMA; HAND PALM; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEMOPHAGOCYTIC SYNDROME; HEPATOMEGALY; HISTIOCYTE; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; LEUKOCYTE COUNT; LIP FISSURE; MACULOPAPULAR RASH; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHARYNGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN EXFOLIATION; SORE THROAT; SYMPTOMATOLOGY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TONSILLITIS;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CEFTRIAXONE; CHILD; DEVELOPING COUNTRIES; DEXAMETHASONE; GAMMA-GLOBULINS; HUMANS; IMMUNOLOGIC FACTORS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 77951705321     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22422     Document Type: Article

References (21)

1. Al-Eid W, Al-Jefri A, Bahabri S. Haemophagocytosis complicating Kawasaki disease. Pediatr Hematol Oncol 2000;17:323-329.
2. Fukazawa R, Ogawa S. Long term prognosis of patients with Kawasaki disease: At risk for future atherosclerosis. J Nippon Med Sch 2009;76:124-133.
3. Taubert K, Shulman S. Kawasaki disease. Am Acad Fam Physicians 1999;59:3093-3104.
4. Ohga S, Ooshima A, Fukushige J, et al. Histiocytic haemophagocytosis in a patient with Kawasaki disease: Changes in the hypercytokinaemic state. Eur J Pediatr 1995;154:539-541.
5. Titze U, Janka G, Schneider EM, et al. Haemophagocytic lymphohistiocytosis and Kawasaki disease: Combined manifestation and differential diagnosis. Pediatr Blood Cancer 2009;53: 493-495.
6. Palazzi DL, McClain KL, Kaplan SL. Haemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J 2003;22:663-665.
7. Avcin T, Tse SML, Schneider R, et al. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. J Pediatr 2006;148:683-686. (Pubitemid 43776910)
8. Muise A, Tallett SE, Silverman ED. Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome. Pediatrics 2003;112:495-497.
9. Cummings C, McCarthy P, Van Hoff J, et al. Kawasaki disease associated with reactive hemophagocytic lymphohistiocytosis. Pediatr Infect Dis J 2008;27:1116-1118.
10. Kaneko K, Takahashi K, Fujiwara S, et al. Kawasaki's disease followed by haemophagocytic syndrome. Eur J Pediatr 1998;157: 610-611. (Pubitemid 28311497)
11. Rakotovao DN, Miandrisoa RM, Ramanitrarivo VL, et al. Kawasaki's disease: A case report from Madagascar. Med Trop 2008;68:637-639.
12. Palazzi DL, McClain KL, Kaplan SL. Haemophagocytic syndrome in children: An important diagnostic consideration in fever of unknown origin. Clin Infect Dis 2006;36:306-312.
13. Janka GE. Haemophagocytic syndromes. Blood Rev 2007;21: 245-253.
14. Gans HA, Lewis DB. Haemophagocytic lymphohistiocytosis and macrophage activation syndrome. Principals and practice of pediatric infectious diseases, 3rd edition. Churchill Livingstone, Philadelphia, 2008.
15. Domachowske JB. Infectious triggers of hemophagocytic syndrome in children. Pediatr Infect Dis 2006;25:1067-1068.
16. Hesseling PB, Wessels G, Egeler RM, et al. Simultaneous occurrence of viral-associated haemophagocytic syndrome and Langerhans cell histiocytosis: A case report. Pediatr Hematol Oncol J 1995;12:135-141.
17. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for HLH. Pediatr Blood Cancer 2007;48: 124-131.
18. Olivieri L, Arling B, Friberg M, et al. Coronary artery Z score regression equations and calculators derived from a large heterogeneous population of children undergoing echocardiography. J Am Soc Echocardiogr 2009;22:159-164.
19. Hui WH, Ng DKK, Kwok KL, et al. Haemophagocytic lymphohistiocytosis in an infant: Important aspects in management. HK J Paediatr 2007;12:205-211.
20. Imashuku S, Hibi S, Todo S. Hemophagocytic lymphohistiocytosis in infancy and childhood. J Pediatr 130:352-357.
21. Stéphan JL, Koné-Paut I, Galambrun C, et al. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Pediatr Rheum 2001;40:1285-1292.